198 related articles for article (PubMed ID: 28991657)
1. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
2. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
4. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
5. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
7. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
[TBL] [Abstract][Full Text] [Related]
9. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
10. Neurological symptoms and natural course of xeroderma pigmentosum.
Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
[TBL] [Abstract][Full Text] [Related]
11. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
[TBL] [Abstract][Full Text] [Related]
12. Progressive length-dependent polyneuropathy in xeroderma pigmentosum group A.
Tsuji Y; Ueda T; Sekiguchi K; Nishiyama M; Kanda F; Nishigori C; Toda T; Matsumoto R
Muscle Nerve; 2020 Oct; 62(4):534-540. PubMed ID: 32696477
[TBL] [Abstract][Full Text] [Related]
13. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.
Hirai Y; Kodama Y; Moriwaki S; Noda A; Cullings HM; Macphee DG; Kodama K; Mabuchi K; Kraemer KH; Land CE; Nakamura N
Mutat Res; 2006 Oct; 601(1-2):171-8. PubMed ID: 16905156
[TBL] [Abstract][Full Text] [Related]
15. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity.
Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S
Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
17. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
[TBL] [Abstract][Full Text] [Related]
18. [Siblings with xeroderma pigmentosum group A showing mild cutaneous and various neurological manifestations].
Kuru S; Yasuma M; Sakai M; Konagaya M; Moriwaki S
Rinsho Shinkeigaku; 2006 Feb; 46(2):134-9. PubMed ID: 16619838
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
20. Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model.
Ohnishi H; Kawasaki T; Deguchi T; Yuba S
Cell Reprogram; 2015 Aug; 17(4):268-74. PubMed ID: 26090552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
